指南与共识重症综合管理与镇静镇痛复苏、休克与脓毒症

2025年中心静脉导管相关血流感染预防与治疗实践指南

[Practice guideline on the prevention and treatment of central line associated bloodstream infection in 2025].
指南 / 共识 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论中国重症医学专业委员会基于GRADE系统更新发布52条推荐,聚焦ICU成人中心静脉导管置入、管理及CLABSI预防、诊断与治疗。

中心静脉导管相关血流感染(CLABSI)是留置血管内导管最严重的并发症,也是ICU或医院获得性感染最常见原因之一,显著增加死亡风险、住院时间和医疗经济负担。近年多项大型临床研究为CLABSI诊断、治疗和预防提供了循证支持,全球抗生素耐药流行病学趋势和新抗菌药物的发展也要求调整临床管理策略。中国重症医学专业委员会据此更新修订2007年《血管内导管相关感染预防与治疗指南》,遵循GRADE系统进行证据质量评价,经定义关键临床问题、文献检索、筛选研究、Meta分析、证据合成、专家函审、远程及面对面会议和两轮投票最终定稿。该指南共52条推荐,聚焦ICU成人中心静脉导管患者,涵盖置管部位与技术选择、导管类型与设计、导管管理以及CLABSI预防、诊断和治疗。

要点

  • 中国重症医学专业委员会基于GRADE系统更新发布2025年CLABSI预防与治疗实践指南,共52条推荐,替代2007年版。
  • 指南聚焦ICU成人中心静脉导管患者,涵盖置管部位与技术选择、导管类型与设计、导管管理、CLABSI预防、诊断和治疗。
  • CLABSI是留置血管内导管最严重并发症,显著增加死亡风险、住院时间和医疗经济负担。
  • 全球抗生素耐药流行病学变化和新抗菌药物发展要求调整CLABSI临床管理策略。

适用人群与场景

  • ICU成人中心静脉导管患者。

研究设计与关键结果

  • 制定机构为中国重症医学专业委员会,采用GRADE系统进行证据质量评价。
  • 制定方法包括定义关键临床问题、文献检索、筛选研究、Meta分析、证据合成形成初步推荐,经专家函审、远程及面对面会议和两轮投票最终定稿。
  • 指南共52条推荐,聚焦ICU成人中心静脉导管患者,涵盖置管部位与技术选择、导管类型与设计、导管管理以及CLABSI预防、诊断和治疗。

证据类型、等级与局限

  • 证据类型:指南。
  • 证据分级体系:GRADE系统。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该指南为ICU医护人员提供中心静脉导管管理的最佳实践,规范成人CLABSI临床流程。

指南或共识出处

  • 2025年中心静脉导管相关血流感染预防与治疗实践指南,中国重症医学专业委员会。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Central line associated bloodstream infection (CLABSI) is the most severe complication of indwelling intravascular catheters and one of the most common causes of intensive care unit (ICU)- or hospital-acquired infections. Once CLABSI occurs, it significantly increases the risk of mortality, long of hospital stay, and healthcare economic burden. In recent years, multiple large-scale clinical studies on the diagnosis, treatment, and prevention of CLABSI have been completed, providing evidence-based medical support for related practices. Additionally, evolving global trends in antibiotic resistance epidemiology and the development of novel antimicrobial agents necessitate adjustments in clinical management strategies. Based on these developments, the Chinese Society of Critical Care Medicine has updated and revised the Guideline on the Prevention and Treatment of Intravascular Catheter-Related Infections (2007). This guideline was developed following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system for evidence quality assessment. Guided by clinical questions, the working group initiated the process by defining key clinical issues, conducting literature searches, screening studies, performing meta-analyses, and synthesizing evidence-based findings to draft preliminary recommendations. These recommendations underwent iterative revisions through expert panel reviews, remote and in-person meetings, and two rounds of voting by the Standing Committee of the Chinese Society of Critical Care Medicine before finalization. The guideline comprises 52 recommendations, focusing on adult patients with central venous catheters in ICU. Key areas addressed include: selection of catheter insertion sites and techniques, catheter type and design, catheter management, prevention, diagnosis, and treatment of CLABSI. The guideline aims to provide ICU healthcare professionals with best practices for central line management, ensuring standardized clinical protocols for adult CLABSI.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chinese Society Of Critical Care Medicine. [Practice guideline on the prevention and treatment of central line associated bloodstream infection in 2025]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40201989. doi:10.3760/cma.j.cn121430-20250301-00199

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。